(Q73417857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

K J Skeith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M S Hussain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R T Coutts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J A Avina-Zubieta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A S Russell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

291-295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

3 November 2019

cites work

1 reference

12 December 2020

Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine

1 reference

12 December 2020

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Clinical consequences of polymorphic drug oxidation

1 reference

12 December 2020

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

1 reference

12 December 2020

Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

1 reference

12 December 2020

Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

1 reference

12 December 2020

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

12 December 2020

Narcotic analgesics and debrisoquine polymorphism

1 reference

12 December 2020

Lack of association between fibromyalgia and sleep apnoea syndrome

1 reference

12 December 2020

Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6

1 reference

12 December 2020

Zopiclone in the treatment of sleep abnormalities in fibromyalgia.

1 reference

12 December 2020

Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests.

1 reference

12 December 2020

Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

1 reference

12 December 2020

Debrisoquine oxidative phenotyping and psychiatric drug treatment

1 reference

12 December 2020

A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis.

1 reference

12 December 2020

Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis.

1 reference

12 December 2020

Imipramine for the treatment of fibrositis: a therapeutic trial

1 reference

12 December 2020

Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial

1 reference

12 December 2020

Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study

1 reference

12 December 2020

High plasma concentrations of desmethylclomipramine after chronic administration of clomipramine to a poor metabolizer

1 reference

12 December 2020

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

12 December 2020

Psychiatric and psychologic aspects of fibromyalgia syndrome.

1 reference

12 December 2020

A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome

1 reference

12 December 2020

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

1 reference

12 December 2020

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02238966

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9184268%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference